Parallel Advisors LLC reduced its stake in Waters Co. (NYSE:WAT) by 70.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 120 shares of the medical instruments supplier’s stock after selling 285 shares during the period. Parallel Advisors LLC’s holdings in Waters were worth $26,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently modified their holdings of the company. Fundsmith LLP boosted its holdings in shares of Waters by 0.9% during the 1st quarter. Fundsmith LLP now owns 5,026,757 shares of the medical instruments supplier’s stock worth $1,265,285,000 after buying an additional 43,498 shares during the period. Geode Capital Management LLC raised its stake in shares of Waters by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 1,025,341 shares of the medical instruments supplier’s stock valued at $193,104,000 after buying an additional 50,700 shares in the last quarter. Northern Trust Corp increased its position in shares of Waters by 5.9% during the 1st quarter. Northern Trust Corp now owns 991,892 shares of the medical instruments supplier’s stock worth $249,670,000 after purchasing an additional 54,938 shares in the last quarter. Champlain Investment Partners LLC increased its position in shares of Waters by 1.5% during the 1st quarter. Champlain Investment Partners LLC now owns 838,625 shares of the medical instruments supplier’s stock worth $211,090,000 after purchasing an additional 12,365 shares in the last quarter. Finally, Jensen Investment Management Inc. increased its position in shares of Waters by 1.4% during the 2nd quarter. Jensen Investment Management Inc. now owns 446,637 shares of the medical instruments supplier’s stock worth $96,134,000 after purchasing an additional 5,976 shares in the last quarter. 95.62% of the stock is owned by institutional investors.
Several equities research analysts have weighed in on WAT shares. Wolfe Research started coverage on shares of Waters in a research report on Thursday, May 30th. They issued an “underperform” rating for the company. Zacks Investment Research raised shares of Waters from a “sell” rating to a “hold” rating and set a $217.00 price objective on the stock in a research note on Wednesday, May 22nd. Bank of America downgraded shares of Waters from a “neutral” rating to an “underperform” rating in a report on Tuesday, July 16th. Cleveland Research downgraded shares of Waters from a “neutral” rating to an “underperform” rating in a report on Wednesday, June 12th. Finally, ValuEngine downgraded shares of Waters from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $210.54.
Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.11 by $0.03. Waters had a return on equity of 50.64% and a net margin of 24.09%. The firm had revenue of $599.20 million for the quarter, compared to analysts’ expectations of $601.46 million. During the same period in the prior year, the business earned $1.95 EPS. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Equities analysts expect that Waters Co. will post 9.01 earnings per share for the current year.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Further Reading: Green Investing
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.